September 5, 2025 · Form 4 insider transaction
Third Rock Ventures IV, L.P. sold 642,906 shares of Tango Therapeutics Incorporated at $7.00 per share, a transaction worth $4.50M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.